Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,095 recruiting studies in this area right now.
By phase
- Not applicable4,200
- Phase 2594
- Phase 1413
- Phase 3325
- Phase 4252
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer337
- Cervical Cancer224
- Endometrial Cancer209
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer112
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California350
- Alabama153
- Texas120
- Massachusetts117
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,095 total
- NCT06523543Recruiting
Early fetal genetic test using placental cells
This study tests a new method to detect genetic information from a pregnancy as early as 7 weeks, using cells from the placenta. It may help identify certain genetic conditions earlier than standard tests.
Montpellier, FranceAges 18 years+ - NCT06520982RecruitingEarly Phase 1
Early brain and blood vessel changes in aging women
This study looks at how blood vessels in the brain change as women age. It may help understand why some women have higher risk for certain health problems later in life.
Columbia, MissouriAges 18–70 - NCT06521398Recruiting
Postpartum Care for Preterm NICU Babies
This study focuses on helping new mothers of preterm babies (born before 34 weeks) who are getting care in the NICU at HUP. It tests a program to support your transition home after giving birth, so you and your baby can thrive.
Philadelphia, PennsylvaniaAges 16 years+ - NCT06531642RecruitingPhase 2/Phase 3
Early acid-reducing drug for kidney injury after severe bleeding
This study tests whether giving a common acid-reducing medication (a proton pump inhibitor, or PPI) early after severe bleeding from trauma can help protect the kidneys from injury. It compares this early treatment to usual care.
Houston, TexasAges 18 years+ - NCT06521801Recruiting
The Heart-Kidney Health Registry Study
This is an observational registry that collects information from people with kidney disease who are seen by the kidney team at Royal London Hospital. It helps researchers study heart and kidney health over time without needing extra tests or visits.
LondonAges 16 years+ - NCT06525623Recruiting
Early albumin for kidney injury in cirrhosis
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
Boston, MassachusettsAges 18 years+ - NCT06525571RecruitingPhase 3
Blue light surgery for high-risk bladder cancer
This trial tests if using blue light during surgery helps remove all cancer in people with high-risk non-muscle invasive bladder cancer. It may lower the chance of the cancer coming back.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06518668Enrolling by invitationPhase 1
NKX019 cell therapy for lupus
This study tests a new therapy called NKX019, which uses specially engineered natural killer cells to target a protein on lupus cells. It is for people with moderate to severe lupus that has not responded to standard treatments, especially those with active kidney inflammation.
New York, New YorkAges 18–65 - NCT06525831Recruiting
3D printing kidney models for surgery planning
This trial uses MRI scans to create 3D printed models of kidneys with tumors. It aims to help surgeons plan operations. You may be able to join if you are scheduled for kidney tumor removal.
BordeauxAges 18 years+ - NCT06526741Recruiting
Alport Syndrome Patient Registry
This registry collects health information from people with Alport syndrome to help researchers better understand the condition and improve future treatments.
Scottsdale, ArizonaAges birth+ - NCT06529042Enrolling by invitation
Sickle Cell Risk in Pregnancy Tool Study
This study is developing a risk assessment tool to help predict complications in pregnant women with sickle cell disease. It reviews medical records from women who have received prenatal care and given birth at participating hospitals.
Baltimore, MarylandAges 16–60 - NCT06528990RecruitingPhase 2
Telehealth help for ostomy self-care
This study tests a telehealth program to help you manage your ostomy after surgery. If you have bladder or colorectal cancer and are getting an ostomy, you and a caregiver can learn skills to handle your new stoma from home using video calls.
Duarte, CaliforniaAges 18 years+ - NCT06529822RecruitingPhase 1
Personalized cancer vaccine for solid tumors with residual disease
This trial tests a personalized cancer vaccine designed to help your immune system fight any remaining cancer cells after surgery. It is for people with certain solid tumors—like bladder, stomach, melanoma, or lung cancer—that show signs of disease through a blood test.
Orlando, FloridaAges 18 years+ - NCT06528405RecruitingPhase 2
SGLT2 inhibitor study for acute kidney disease patients
This study tests whether SGLT2 inhibitors (a type of diabetes drug that also helps kidneys) can help patients with acute kidney disease. It may be an option if you have diabetes or chronic kidney disease along with acute kidney problems.
TaipeiAges 18–80 - NCT06527456Recruiting
Boosting cervical cancer screening with help from your doctor
This study tests whether extra support from your regular general practitioner can help more women get screened for cervical cancer. If you qualify, your GP will work with you to make sure you don't miss your screening appointment.
CréteilAges 25–65 - NCT06517810Recruiting
QUELIMMUNE pediatric surveillance registry
This registry tracks children treated with QUELIMMUNE therapy to see how well it works over time. It helps doctors learn more about the treatment's safety and effects in kids.
Birmingham, AlabamaAges Up to 22 years - NCT06516653Recruiting
Study of VasQ implant for new dialysis fistula support
This study tests a small mesh support called VasQ that is placed around your new fistula to help it heal and stay open longer. It is for people who are getting a new fistula for dialysis access.
Long Beach, CaliforniaAges 18–80 - NCT06515613RecruitingPhase 1
Testing CTIM-76 for recurrent ovarian and other advanced cancers
This trial tests a new drug, CTIM-76, in people whose ovarian, testicular, or endometrial cancer has come back and is not responding to standard treatments. It aims to see if the drug can shrink tumors or stop them from growing.
Little Rock, ArkansasAges 18 years+ - NCT06527157Recruiting
Study on reproductive cancers in women
This study is looking at women who have unusual bleeding or bleeding after menopause to find better ways to diagnose reproductive cancers like endometrial cancer. If you are 45 or older and still have your uterus, you may be able to help.
Birmingham, AlabamaAges 45–100 - NCT06527872Recruiting
Study of belimumab for lupus kidney disease in real life
This study looks at how well belimumab (Benlysta) works in real-world settings for adults with lupus nephritis (kidney inflammation caused by lupus). If you started belimumab in the past 6–24 months, the researchers will review your medical records to see how your kidney health has changed.
Baltimore, MarylandAges 18 years+ - NCT06525636RecruitingPhase 1/Phase 2
Study of a new drug for X-linked hypophosphatemia
This study tests an investigational drug called KK8123 for adults with X-linked hypophosphatemia (XLH), a rare condition that causes low phosphate levels and can lead to bone problems. The goal is to see if it helps improve phosphate levels in the body.
San Francisco, CaliforniaAges 18–65 - NCT06513962RecruitingPhase 3
Triptorelin to protect ovaries in young women with cancer
This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.
Birmingham, AlabamaAges Up to 39 years - NCT05255289Recruiting
Midurethral sling surgery for stress urine leakage
This trial studies how safe and effective a midurethral sling operation is for people with stress urinary incontinence (urine leakage with coughing, laughing, or exercise). It also requires special bladder testing before and after surgery to measure results.
New Taipei CityAges 30–100 - NCT05932862RecruitingPhase 1
Test drug XL309 for advanced tumors with HRR gene changes
This early-phase study tests XL309 (and sometimes a mix of XL309 with another treatment) in people whose advanced solid tumors have specific DNA-repair gene changes, such as BRCA1/2 or other HRR-related changes. It aims to see how well the drug works and what dose is safest for these cancers.
Fountain Valley, CaliforniaAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,095 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,917 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.